TherapeuticsMD (TXMD) Interest Expenses (2010 - 2026)

TherapeuticsMD's Interest Expenses history runs 17 years deep, the most recent figure standing at $1.4 million for Q1 2026.

• Quarterly Interest Expenses rose 257.03% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (up 257.03% YoY) and the FY2025 annual result came in at $1.4 million, down 99.27% from the prior year.
• Interest Expenses was $1.4 million for Q1 2026 at TherapeuticsMD, up from $1000.0 in the prior quarter.
• Across five years, Interest Expenses topped out at $22.1 million in Q1 2022 and bottomed at $1000.0 in Q4 2025.
• A 5-year average of $2.6 million and a median of $438000.0 in 2023 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2022 — Interest Expenses sank 98.49% — and 2024, when it soared 501.37%.
• TherapeuticsMD's Interest Expenses stood at $200000.0 in 2022, then slumped by 74.2% to $51600.0 in 2023, then sank by 96.12% to $2000.0 in 2024, then plunged by 50.0% to $1000.0 in 2025, then surged by 137000.0% to $1.4 million in 2026.
• Business Quant data shows TXMD's Interest Expenses at $1.4 million in Q1 2026, $1000.0 in Q4 2025, and $384000.0 in Q3 2025.